Keros Therapeutics, Inc. (KROS)
Pharmaceutical Preparations · Healthcare · $908M
Intrinsic Value (Consensus)
$45.26
Current Price
$46.00
Margin of Safety
-1.6%
1.6% Above Intrinsic Value
Value: $45
Price: $46
Valuation Model Estimates
Current Price: $46.00
DCF (Discounted Cash Flow)
$84.49
Graham Number
$28.20
Earnings Power Value
$22.33
Relative Value (P/E)
$46.00
Dividend Discount Model
Not applicable
—
Consensus Value
$45.26
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Key Financials
- EPS (TTM)
- $2.30
- EPS (Forward)
- $2.42
- Book Value
- $15.36
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 28.7%
- Debt/Equity
- —
- Revenue Growth
- 6775.0%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Data last updated: 2026-06-12
Source: Yahoo Finance